<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-04-20">April 20, 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Lei</forename><surname>Liu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lin</forename><surname>Pang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yunfeng</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ming</forename><surname>Hu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhuo</forename><surname>Shao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Diwei</forename><surname>Huo</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">The 2nd</orgName>
								<orgName type="institution" key="instit1">Affiliated Hospital of Harbin Medical University</orgName>
								<orgName type="institution" key="instit2">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Denan</forename><surname>Zhang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hongbo</forename><surname>Xie</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jingbo</forename><surname>Yang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qiuqi</forename><surname>Liu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Xiujie</forename><surname>Chen</surname></persName>
							<email>chenxiujie@ems.hrbmu.edu.cn</email>
							<affiliation key="aff0">
								<orgName type="department">College of Bioinformatics Science and Technology</orgName>
								<orgName type="institution">Harbin Medical University</orgName>
								<address>
									<addrLine>Heilongjiang Province</addrLine>
									<settlement>Harbin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-04-20">April 20, 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">D85F3BEC2C683B57FA0BE69BBEB57444</idno>
					<note type="submission">Received: January 19, 2017 Accepted: November 16, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>cross-talk genes</term>
					<term>risk pathways</term>
					<term>molecular markers</term>
					<term>hepatocellular carcinoma (HCC)</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Hepatocellular carcinoma (HCC) is the most frequent type of liver cancer with poor survival rate and high mortality.</s><s>Despite efforts on the mechanism of HCC, new molecular markers are needed for exact diagnosis, evaluation and treatment.</s><s>Here, we combined transcriptome of HCC with networks and pathways to identify reliable molecular markers.</s><s>Through integrating 249 differentially expressed genes with syncretic protein interaction networks, we constructed a HCC-specific network, from which we further extracted 480 pivotal genes.</s><s>Based on the cross-talk between the enriched pathways of the pivotal genes, we finally identified a HCC signature of 45 genes, which could accurately distinguish HCC patients with normal individuals and reveal the prognosis of HCC patients.</s><s>Among these 45 genes, 15 showed dysregulated expression patterns and a part have been reported to be associated with HCC and/or other cancers.</s><s>These findings suggested that our identified 45 gene signature could be potential and valuable molecular markers for diagnosis and evaluation of HCC.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Liver cancer, with an increasing incidence rate, is the second most frequent cause of cancer related death worldwide <ref type="bibr" target="#b0">[1]</ref>.</s><s>The most frequent type of liver cancer is hepatocellular carcinoma (HCC), which originates from the main liver cells and accounts for 70%-85% of primary liver cancer, with poor 5-year survival rate and high mortality.</s></p><p><s>Many factors can cause the liver cirrhosis which increases the risk of HCC, including chronic hepatitis B or C infections, heavy and prolonged alcohol consumption, diabetes and obesity and some inherited liver diseases.</s><s>Hepatocellular carcinoma is usually diagnosed by computed tomography or magnetic resonance imaging, followed by a liver biopsy to confirm the diagnosis.</s></p><p><s>Previous studies have identified many drivers with frequent mutations and aberrant expressions in HCC, such as TERT, TP53, CTNNB1 and ARIDA1A <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Although further analyses explored the mechanism of tumorgenesis mediated by these drivers, the understanding of liver cancer remains to improve and deepen.</s><s>Therefore, novel molecular markers are still urgently needed, which benefits for early diagnosis and risk assessment.</s></p><p><s>Moreover, hepatocarcinogenesis is a complex multistep process with multiple signaling cascades changed, including vascular endothelial growth factor (VEGF) signaling <ref type="bibr" target="#b3">[4]</ref>, Ras MAPK signaling <ref type="bibr" target="#b4">[5]</ref>, the PI3K/PTEN/Akt/mTOR pathway <ref type="bibr" target="#b5">[6]</ref> and Wnt/β-Catenin pathway <ref type="bibr" target="#b6">[7]</ref>.</s><s>Notably, interactions between signaling pathways frequently occur and have been elucidated in many cancers, which emphasizes the roles of crosstalk between key pathways or regulators in the genesis and development of tumor.</s><s>For example, Lihong Xu and colleagues found that the cross-talk between the PPARδ and prostaglandin (PG) signaling pathways could contribute to the hepatocarcinogenesis through regulating HCC cell growth <ref type="bibr" target="#b7">[8]</ref>.</s><s>The cross-talk between the PI3K/ Akt and MEK/ERK cascades could result in cell cycle arrest and cell survival in order to adapt to endoplasmic Research Paper www.oncotarget.com</s><s>reticulum (ER) stress <ref type="bibr" target="#b8">[9]</ref>.</s><s>Some studies also focused on the cross-talk genes.</s><s>For example, Jiang Du found that the dys-regulated genes in ARLC-SCC enriched for many pathways which showed obvious correlations by sharing cross-talk genes.</s><s>They further identified 8 cross-talk genes which bridge multiple ARLC-SCC-specific pathways as candidate biomarkers <ref type="bibr" target="#b9">[10]</ref>.</s><s>Kang Ae Lee performed a comprehensive analysis to determine the extent of crosstalk between the AHR and HIFs and focused on the 33 shared genes between the two sets of genes exhibiting sensitivity to cross-talk <ref type="bibr" target="#b10">[11]</ref>.</s><s>These findings suggest that, investigating cross-talk between cancer-related pathways and genes can promote our understanding of the mechanism of tumorigenesis.</s></p><p><s>Here, we used expression profiles of HCC to identify markers which could accurately distinguish patients and healthy people, as well as the prognosis of HCC patients, through integrating network and pathway information with our developed method.</s><s>These markers provide valuable choices for diagnosis, targets for treatment and objects for further analysis of HCC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification of differentially expressed genes</head><p><s>In order to identify dysregulated genes during the genesis of HCC, we first obtained the microarray expression profile of a total of 433 samples including cancerous and pericarcinomatous tissues of HCC.</s><s>Using one of the widely used method Limma <ref type="bibr" target="#b11">[12]</ref>, we identified 249 significantly differentially expressed genes, consisting of 219 up-regulated genes and 30 down-regulated genes (Figure <ref type="figure" target="#fig_0">1A</ref>, Supplementary Table <ref type="table">1</ref>).</s><s>Further functional enrichment analysis demonstrated that these dysregulated genes were involved in many cancer-associated biological processes, such as metabolism <ref type="bibr" target="#b12">[13]</ref>, immune system <ref type="bibr" target="#b13">[14]</ref> and especially the cell cycle <ref type="bibr" target="#b14">[15]</ref> (Figure <ref type="figure" target="#fig_0">1B</ref>), suggesting the dominating abnormity of cell proliferation in HCC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The construction of HCC-specific interaction network</head><p><s>Given that a biological process is synergistically regulated by many factors other than independently by one gene, we assumed that the dysregulated genes controlled liver-associated physiological activities through interacting with each other or additional regulators.</s><s>To obtain the dysregulated network of HCC, we mapped the 249 differentially expressed genes to the protein interaction network consisting of 14553 protein-coding genes (PCGs) and 662360 interactions between them, which was built by combining resources from BioGrid and HPRD database.</s><s>Based on this integrated network, we extracted a HCC-specific network which contained differentially expressed genes and their closely associated PCGs (see Method).</s><s>Finally, the HCC-specific network was composed of 522 nodes and 12841 edges (Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>Notably, many genes with large degrees in this subnetwork have been reported to be associated with HCC, such as UBC, SUMO2, SNW1, POLR2A, CDC5L, CDK1, PLK1 and HNRNPK.</s><s>Functional enrichment analysis showed that, compared with the dysregulated genes, genes of HCC-specific network additionally enriched for processes about cell cycle phase transition, innate immune response and NF-kappaB signaling, which were not captured by the dys-regulated genes but were associated with cancer process (Supplementary Table <ref type="table">2</ref>).</s><s>These findings suggested that the subnetwork may contain key regulators of liver pathophysiology, whose aberration may play important roles in HCC mechanism.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The identification of important genes based on HCC-specific network</head><p><s>Considering the importance and biological significance of hub genes in the interaction network and the close relationship of the subnetwork with HCC, we calculated a state score for each gene that combined the extent of the deviation and the degree in the HCCspecific network to characterize its transcription status and importance (see Method).</s><s>Totally, we identified 480 genes which contained 455 up-regulated genes with state scores being positive and 25 down-regulated genes with state scores being negative, for subsequent analysis (Supplementary Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk pathways can distinguish disease and normal samples</head><p><s>The dysregulation of crucial pathways commonly occur in cancer, which were frequently caused by the aberrant activation or repression of key genes.</s><s>Therefore, we used DAVID to obtain the enriched pathways of 455 up-regulated genes and 25 down-regulated genes identified above, respectively.</s><s>Totally, we obtained 31 pathways, among which 9 pathways contained both up-regulated and down-regulated genes, 18 pathways only contained up-regulated genes and 4 pathways only contained downregulated genes.</s></p><p><s>To explore whether these pathways could reflect disease status, we calculated a score for each pathway based on the expression profiles of up-regulated and down-regulated genes.</s><s>Hierarchical clustering analysis of the 31 pathways based on our defined scores could nearly completely distinguish HCC and normal samples (Figure <ref type="figure" target="#fig_2">3</ref>).</s><s>Notably, pathways such as Wnt signaling pathway, cell cycle and TGF-beta signaling pathway showed active status.</s><s>On the contrary, we found that focal adhesion and adhesions junction showed inactive status, which implied the tendency of metastasis.</s><s>Moreover, we observed that many other cancer-associated pathways www.oncotarget.com</s><s>were dysfunctional.</s><s>These results suggested that these pathways could reveal the highlighted cancer-associated changes during the pathogenesis of HCC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The identification of cross-talk genes and their prediction efficiency</head><p><s>The biological regulation network is a complex system, in which the interactions between pathways are common and important to maintain many pivotal biological processes.</s><s>The cross-talk genes are shared by pathways and are considered as indispensable members whose dysfunction may result in serious consequences including diseases.</s><s>To further explore which caused the variety between HCC and control samples, we focused on the cross-talk genes between the 31 pathways identified above.</s><s>Of the 223 gene in all these pathways, we found that 104 genes were shared by at least two pathways, which we considered as cross-talk genes and were used for subsequent analysis (Supplementary Table <ref type="table">4</ref>).</s><s>For example, MAPK1, TP53, EGFR and RB1 were well-known HCCassociated genes whose alteration were frequently observed in multiple layers including genome, transcriptome and epigenome.</s><s>Moreover, we also found some other crosstalk genes which had few reports about HCC, like some subunits of the anaphase-promoting complex/cyclosome (APC/C) complex (ANAPC1, ANAPC2, ANAPC4, ANAPC5, ANAPC7, ANAPC10 and ANAPC11).</s><s>Moreover, the pathways enriched by the 104 cross-talk genes and found that they were involved in many cancerassociated biological processes, such as TGF-beta signaling pathway, Wnt signaling pathway, adherens junction and cell cycle, implying their potential roles in HCC.</s></p><p><s>To extract reprehensive genes from the 104 cross-talk genes, we used Weka <ref type="bibr" target="#b15">[16]</ref> to carry out feature selection and further identified 45 genes which could reflect more information of samples and disease status.</s><s>Then we constructed a model using random forest algorithm based on the expression levels of these 45 genes in the 433 samples.</s><s>Notably, these 45 genes contained 15 differentially expressed genes.</s><s>All these 45 cross-talk model genes were found closely related to cancer (Supplementary Table <ref type="table">5</ref> and Supplementary Table <ref type="table">6</ref>).</s><s>To detect the accuracy of our model, we obtained another two microarray data sets and two RNA-seq data sets.</s><s>We applied our model to these four data sets and found it could accurately distinguish HCC patients and normal individuals.</s><s>The AUC were 0.746 and 0.862 for the two expression profile data sets, as while as 0.690 and 0.750 for the two RNA-seq data sets, respectively (Figure <ref type="figure" target="#fig_3">4</ref>).</s><s>Further, permutation analysis validated the significance of this model in the four data sets with P value of 0.05 (see Method).Taken together, these findings suggested that the 45 cross-talk genes we identified could be valuable biomarkers that were of clinical significance for diagnosis of HCC.</s></p><p><s>As our model was constructed with cross-talk genes which might reveal more mechanism with HCC, we wondered if they could reveal the prognosis of HCC patients.</s><s>We used the 45 cross-talk model genes as a tag and made a survival analysis of HCC patients (Figure <ref type="figure" target="#fig_4">5</ref>, see Method).</s><s>The blue curve represented the survival time of HCC patients with 45 cross-talk model genes not exhibiting changes and the red curve represented survival time of HCC patients exhibiting changes in at least one of these 45 cross-talk genes.</s><s>A P value of 0.03 indicated that the 45 cross-talk genes may also serve as biomarkers to assess the prognosis of HCC patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Hepatocellular carcinoma severely influences the quality of patients' life, which promotes us to develop new In this paper, we integrated expression, networks and pathways to identify valuable markers of HCC.</s><s>The 45 gene signature we identified could accurately distinguish HCC patients and normal individuals, implying their potential clinical application.</s></p><p><s>The liver can regenerate after either surgical removal or after chemical injury.</s><s>It is known that as little as 25% of the original liver mass can regenerate back to its full size <ref type="bibr" target="#b16">[17]</ref>.</s><s>Consistently, the differentially expressed genes mainly enriched in cell cycle-associated processes, such as mitotic cell cycle, cell cycle process and cell division, demonstrating that these dysfunctional genes could really reflect the physiological and pathological characteristics of HCC.</s></p><p><s>Almost all of the biological processes were precisely regulated by a diversity of factors, which make up a complicated network.</s><s>Here, we extracted a subnetwork which contained many HCC-associated genes, such as UBC, SUMO2, SNW1, POLR2A, CDC5L, CDK1, PLK1 and HNRNPK.</s><s>Interestingly, UBC and SUMO2 were well-known ubiquitin-associated genes, which have been reported to be involved in cell-cycle process <ref type="bibr" target="#b17">[18]</ref> and DNA damage <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>The knockdowns of the spliceosome protein SNW1 could result in mitotic arrest <ref type="bibr" target="#b20">[21]</ref>.</s><s>Since RNA polymerase II mediates the transcription of all protein-coding genes in eukaryotic cells, POLR2A, as the catalytic subunit of it, was frequently detected to acquire mutations in cancers <ref type="bibr" target="#b21">[22]</ref>, suggesting its important roles in the cancer development.</s><s>Moreover, many studies have found that CDC5L, CDK1 and PLK1 were crucial regulators of cytokinesis <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>All these findings were concordant with the results above, suggesting that cell cycle and cytokinesis may be the major disturbed processes during the genesis of HCC.</s></p><p><s>During the cancer development, many key pathways showed aberrant changes.</s><s>Notably, interactions between pathways are also of significance for normal life activities, the destruction of which may cause severe diseases including cancer.</s><s>The cross-talk genes are the ones shared by pathways, which are considered as key regulators in biological processes.</s><s>Based on this assumption, we finally identified 45 cross-talk genes, selected from the 31 risk pathway we identified through combining the defined upand down-regulated genes.</s><s>We assumed that these cross-talk genes could reflect more disease-associated information since they participate in different pathway regulation simultaneously and help us to accurately characterize the features of patients with HCC.</s><s>Consistently, applying these 45 genes to additional data sets showed that they could distinguish HCC patients and normal individuals with a high precision.</s><s>Moreover, among the 45 genes, some genes has been considered as HCC biomarkers, such as SUMO2, PLK1, CCND1, CDK2 and RB1 <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>, suggesting that our method could capture the key changes of transcriptome in HCC development.</s><s>Taken together, our work provided valuable sources of HCC-associated biomarkers which could   be the alternative objects for future studies to further explore the mechanism and extend our understanding of HCC, which are all benefit for the clinical diagnosis and treatment of HCC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data acquirement</head><p><s>The expression profile data (GSE36376) of hepatocellular carcinoma, which was used for identification of molecular biomarkers, contains 240 patient samples and 193 control samples.</s></p><p><s>We used two expression profile data sets and two RNA-seq data sets for validation of the prediction efficiency of molecular biomarkers.</s><s>The two expression profile data sets were GSE25097, which contained 268 HCC tumor and 243 adjacent non-tumor samples, and GSE49515, which contained 10 HCC tumor and 10 adjacent non-tumor samples.</s><s>The two RNA-seq data sets were GSE64041, which contained 60 HCC tumor and 60 adjacent non-tumor samples, and GSE95698, which contained 3 HCC tumor and 3 adjacent non-tumor samples.</s><s>An independent dataset containing mRNA data and clinical information of 370 HCC patients from The Cancer Genome Atlas (TCGA-LIHC, https:// cancergenome.nih.gov/) was used to analyze survival time.</s><s>The cBioPortal database was used to generate a K-M Survival curve using cross-talk model genes <ref type="bibr" target="#b26">[27]</ref>.</s></p><p><s>All these data were downloaded from GEO database (http://www.ncbi.nlm.nih.gov/geo/).</s><s>All probe expression profile data were converted to gene symbol according to their platforms information.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identify differentially expressed genes</head><p><s>We used the scale function of R to standardize the expression profiles.</s><s>The differential expression analysis between tumor and control samples were carried out by the R package Limma <ref type="bibr" target="#b11">[12]</ref>.</s><s>Limma is one of the most commonly used statistical methods for analysis of differential expression, which is based on the empirical Bayes linear modeling approach.</s><s>Genes with the P value &lt; 0.05 and absolute fold change &gt; 1.5 were considered as differentially expressed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The construction of HCC-specific network</head><p><s>First, we downloaded the interaction pairs of genes from BioGrid <ref type="bibr" target="#b27">[28]</ref> and HPRD <ref type="bibr" target="#b28">[29]</ref> database, respectively.</s><s>Then, the union of these two sets of interaction pairs was used to construct a background network.</s><s>Second, we mapped the 249 differentially expressed genes to the background network and extracted the genes which had at least five direct interactions with differentially expressed genes.</s><s>Finally, these genes and differentially expressed genes made up a subnetwork, which was called the HCCspecific network.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The state score</head><p><s>To further identify important genes, we determined a state score (W) for each gene in the HCC-specific network, which combined the extent of the deviation (E) and the degree in the network (D) and was calculated as follows: W = E * D. To calculate E, we first defined an interval (I) based on the expression profile of control samples for gene i: I = M-N, where M was calculated as the mean + standard deviation and N was calculated as the mean -standard deviation for gene i.</s><s>Thus, if the expression (exp) of one gene in one sample did not exceed its I, we considered this gene intended to show a non-cancer expression pattern and E = 0; Otherwise, E = exp-M when exp was more than M and E = exp-N when exp was less than M. The genes with more absolute W were considered as more important, where genes were considered as up-regulated if W was positive and down-regulated if W was negative.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Calculate pathway scores</head><p><s>For pathway P in each sample, which contains m up-regulated genes and n down-regulated genes, we calculated a score as following: pathwayscore</s></p><formula xml:id="formula_0">= ( ) ( ) ∑ ∑ log d d i i m j j n − µ − µ 2 1 2 1</formula><p><s>where d i is the expression level of up-regulated gene i in HCC samples and μ i is the mean expression level of gene i in control samples.</s><s>Similarly, d j and μ j represent the expression level of down-regulated gene j in HCC samples and the mean expression level of gene j in control samples, respectively.</s><s>If the pathwayscore is positive, we consider the pathway shows an active pattern; if the pathwayscore is negative, the pathway is considered to show an inactive pattern.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generation of random forest regression model</head><p><s>Random forest is an ensemble method which combines many classification or regression trees <ref type="bibr">[30]</ref>.</s><s>Random forest algorithm has been widely used in the field of bioinformatics, such as transcriptional regulation <ref type="bibr" target="#b29">[31]</ref>.</s><s>Random forest can cope with a large set of correlated variables as well as complex interaction structures and it has already shown excellent performance without any tuning parameters <ref type="bibr" target="#b30">[32]</ref>.</s><s>In random forest, two methods are used to ensure the models to reject randomness: (i) Bootstrap aggregation, that is, each tree in the forest is constructed based on a set of randomly selected samples from the training cases (default to 70% for regression).</s><s>(ii) Random Subspace Method, that is, a small group of input variables are selected at random, at each node to split (default to 30% for regression).</s><s>The final decision is generated by majority voting from aggregation of the predictions of all trees.</s></p><p><s>For the classification model, we used the 433 samples which were initially analyzed as training set and a second set of data which contained 511 samples were used as test set (GSE25097).</s><s>A forest of 500 trees was fitted to distinguish HCC patients and normal individuals.</s><s>The other three test sets (GSE49515, GSE64041 and GSE95698) did the same course as above.</s></p><p><s>The random forest model was constructed using the R package "randomForest" (version: 4.6-12).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Significance analysis of the model</head><p><s>To validate the significance of our model identified using random forest algorithm, we randomly selected 45 genes from all genes commonly contained by the two data set (the training data set and one test set) and trained a model based on the initial expression profile of 433 samples.</s><s>Then the model was applied to each test set to distinguish HCC patients and normal individuals.</s><s>For every test set, this process was repeated for 1000 times and the P value was calculated through determining how many times the AUCs were more than the observed one.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: The analysis of differentially expressed genes.</s><s>(A) Heatmap showing the 249 significantly differentially expressed genes, consisting of 219 up-regulated genes and 30 down-regulated genes.</s><s>(B) Functional enrichment analysis of the differentially expressed genes with x axis represents the negative log10-transformed P values.</s></p></div></figDesc><graphic coords="3,58.34,490.09,496.80,194.64" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: The HCC-specific network.</s><s>Red and green nodes represent up-regulated and down-regulated genes, respectively.</s><s>Blue nodes represent the introduced genes which connect directly to the differentially expressed genes in the background network.</s></p></div></figDesc><graphic coords="4,143.18,394.50,327.13,300.34" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 :</head><label>3</label><figDesc><div><p><s>Figure 3: The heatmap showing the hierarchical clustering of all samples using the scores of 31 identified pathways.</s></p></div></figDesc><graphic coords="5,112.75,48.35,387.50,319.27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 :</head><label>4</label><figDesc><div><p><s>Figure 4: The ROC curve of our model showing its power of distinguishing HCC patients with normal individuals in additional two array data (A and B) and two RNA-seq data (C and D).</s></p></div></figDesc><graphic coords="5,61.03,406.50,491.43,286.43" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 :</head><label>5</label><figDesc><div><p><s>Figure 5: Survival analysis of HCC patients with 45 cross-talk model genes as a tag.</s></p></div></figDesc><graphic coords="6,58.34,409.46,496.80,293.64" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS AND FUNDING</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p><s>Lei Liu and Yunfeng Wang conceived and designed the study.</s><s>Ming Hu, Zhuo Shao, Jingbo Yang performed the experiments.</s><s>Lin Pang wrote the paper.</s><s>Xiujie Chen, Denan Zhang and Qiuqi Liu reviewed and edited the manuscript.</s><s>Diwei Huo and Hongbo Xie participated in the revised work.</s><s>All authors read and approved the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICTS OF INTEREST</head><p><s>The authors declare no other competing interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Global cancer statistics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Center</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page">31</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Integrated analysis of somatic mutations and focal copy-Oncotarget 21266 www.oncotarget.com number changes identifies key genes and pathways in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">C</forename><surname>Guichard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Amaddeo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Imbeaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ladeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pelletier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Maad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Calderaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bioulacsage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Letexier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Degos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="694" to="698" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning</title>
		<author>
			<persName><forename type="first">A</forename><surname>Villanueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Llovet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="73" to="74" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment</title>
		<author>
			<persName><forename type="first">E</forename><surname>Horwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Andreozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nemeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shoham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pappo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schweitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tornillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kanarek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Quagliata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Discovery</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="730" to="743" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo</title>
		<author>
			<persName><forename type="first">P</forename><surname>Newell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Toffanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Villanueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Minguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cabellos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Savic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Melgarlesmes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="725" to="733" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The mTOR pathway in hepatic malignancies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bhat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sonenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Gores</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="810" to="818" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Wntpathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lachenmayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alsinet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Savic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cabellos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Toffanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Villanueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Minguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Newell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="4997" to="5007" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cross-talk between Peroxisome Proliferator-Activated Receptor and Cytosolic Phospholipase A2/Cyclooxygenase-2/Prostaglandin E2 Signaling Pathways in Human Hepatocellular Carcinoma Cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="11859" to="11868" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Oncology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1749" to="1757" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Pathway deviation-based biomarker and multi-effect target identification in asbestos-related squamous cell carcinoma of the lung</title>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="579" to="586" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Identification and characterization of genes susceptible to transcriptional cross-talk between hypoxia and dioxin signaling cascades</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Burgoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lamb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Zacharewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hogenesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lapres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemical Research in Toxicology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1284" to="1293" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Linear models and empirical bayes methods for assessing differential expression in microarray experiments</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Smyth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Statistical Applications in Genetics and Molecular Biology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1" to="28" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cancer cell metabolism: Warburg and beyond</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Sabatini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page">703</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Allison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page">205</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Proliferation, cell cycle and apoptosis in cancer</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Evan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">411</biblScope>
			<biblScope unit="page" from="342" to="348" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Weka: Practical machine learning tools and techniques with java implementations</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Witten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Engineering Online</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="95" to="97" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Liver regeneration</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Michalopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Defrances</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="60" to="66" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schimmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Eifler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Sigurðsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Cuijpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Hendriks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Verlaan-De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Kelstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Francavilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Medema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Olsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cell</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1053" to="1066" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Hendriks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Treffers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Verlaan-De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Vertegaal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Reports</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1778" to="1791" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Seong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Ka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Communications</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="5483" to="5483" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Functional Genomic Analysis of Cell Division by Endoribonuclease-Prepared siRNAs</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kittler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Buchholz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="564" to="567" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Harmancı</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Youngblood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Baranoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Ercansencicek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Weintraub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hnisz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1253" to="1259" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Cdk1/Erk2-and Plk1-Dependent phosphorylation of a centrosome protein, cep55, is required for its recruitment to midbody and cytokinesis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fabbro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sarcevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Gabrielli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Nigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Developmental Cell</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="477" to="488" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cancer: An essential passenger with p53</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bradner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">520</biblScope>
			<biblScope unit="page" from="626" to="627" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Tunable current driver and operating method thereof. US Patent: US 8184486 B2</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012-05-22">May 22, 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Tumor markers for hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="593" to="598" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Aksoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dogrusoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dresdner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Sumer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jacobsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Larsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science Signaling</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The BioGRID interaction database: 2013 update</title>
		<author>
			<persName><forename type="first">A</forename><surname>Chatraryamontri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Breitkreutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heinicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Boucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ramage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="816" to="823" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Human Protein Reference Database--2009 update</title>
		<author>
			<persName><forename type="first">Keshava</forename><surname>Prasad</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Goel</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kandasamy</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Keerthikumar</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mathivanan</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Telikicherla</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Raju</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shafreen</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Venugopal</surname></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
			<affiliation>
				<orgName type="collaboration">www.oncotarget.com 30. Breiman L. Random Forest</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="5" to="32" />
			<date type="published" when="2001">2009. 2001</date>
		</imprint>
	</monogr>
	<note>Machine Learning.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Understanding transcriptional regulation by integrative analysis of transcription factor binding data</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexander</forename><forename type="middle">R</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Leng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Rozowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Djebali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ruan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Research</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">1658</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Practical experiences on the necessity of external validation</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>König</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Weimar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Diener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ziegler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Statistics in Medicine</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="5499" to="5511" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
